Exelixis, Inc. (EXEL)
56.12
-1.31
(-2.28%)
USD |
NASDAQ |
Sep 11, 16:00
56.14
+0.02
(+0.04%)
After-Hours: 20:00
Exelixis Price : 56.12 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 56.76 | 57.43 | 54.54 | 56.12 | 2.917M |
| Sep 10, 2026 | 58.33 | 58.33 | 57.23 | 57.43 | 1.790M |
| Sep 09, 2026 | 57.60 | 58.36 | 56.95 | 58.33 | 1.770M |
| Sep 08, 2026 | 58.97 | 59.41 | 57.55 | 57.67 | 2.539M |
| Sep 04, 2026 | 58.50 | 59.26 | 58.46 | 59.01 | 1.581M |
| Sep 03, 2026 | 58.75 | 59.72 | 58.20 | 59.13 | 2.142M |
| Sep 02, 2026 | 57.21 | 59.11 | 56.70 | 58.53 | 2.851M |
| Sep 01, 2026 | 54.75 | 56.97 | 54.75 | 56.89 | 2.414M |
| Aug 31, 2026 | 54.10 | 55.02 | 53.43 | 54.64 | 2.246M |
| Aug 28, 2026 | 55.14 | 55.25 | 54.12 | 54.45 | 1.487M |
| Aug 27, 2026 | 55.76 | 56.08 | 54.83 | 55.26 | 1.490M |
| Aug 26, 2026 | 56.54 | 56.90 | 56.06 | 56.10 | 1.817M |
| Aug 25, 2026 | 54.95 | 56.74 | 54.95 | 56.72 | 2.024M |
| Aug 24, 2026 | 53.89 | 54.79 | 53.39 | 54.55 | 2.423M |
| Aug 21, 2026 | 53.74 | 54.68 | 53.70 | 54.08 | 1.950M |
| Aug 20, 2026 | 53.76 | 54.50 | 53.44 | 53.69 | 1.951M |
| Aug 19, 2026 | 53.46 | 54.58 | 53.10 | 54.39 | 2.504M |
| Aug 18, 2026 | 52.32 | 53.36 | 52.11 | 53.12 | 1.291M |
| Aug 17, 2026 | 51.25 | 52.70 | 50.80 | 52.32 | 2.373M |
| Aug 14, 2026 | 50.32 | 51.29 | 50.02 | 51.24 | 2.343M |
| Aug 13, 2026 | 50.54 | 51.14 | 49.97 | 50.61 | 1.949M |
| Aug 12, 2026 | 51.00 | 51.52 | 50.30 | 50.38 | 2.939M |
| Aug 11, 2026 | 52.87 | 53.49 | 51.14 | 51.33 | 2.039M |
| Aug 10, 2026 | 54.00 | 54.02 | 52.47 | 52.96 | 3.350M |
| Aug 07, 2026 | 52.69 | 54.14 | 52.17 | 54.07 | 3.550M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 248.68 |
| BioMarin Pharmaceutical, Inc. | 65.68 |
| Cytokinetics, Inc. | 73.77 |
| Emergent BioSolutions, Inc. | 6.23 |
| Gilead Sciences, Inc. | 143.72 |
Price Related Metrics
| PE Ratio | 17.63 |
| PS Ratio | 6.231 |
| PEG Ratio | 0.3345 |
| Price to Book Value | 7.576 |
| Price to Free Cash Flow | 12.95 |
| Earnings Yield | 5.67% |
| Market Cap | 13.97B |
| PEGY Ratio | 0.3345 |
| Operating PE Ratio | 15.30 |
| Normalized PE Ratio | 17.35 |